Canabo Medical Receives Grant for Large Opioid Reduction Study

Although the Attorney General of the United States has called the use of medical cannabis as desperate and only slightly less awful than heroin, the miracle plant continues to save lives every day.

One of the most significant positive externalities of the legal cannabis movement has been the decrease in the number of opioid overdose deaths in states with legal medical cannabis programs.

The DEA Wants To Study The Medical Benefits Of Cannabis, But The DOJ Is Stonewalling Them

Although CNN reported that a study found little evidence that marijuana helps treat chronic pain and PTSD, we beg to differ…

Two studies published in the journal Annals of Internal Medicine found that there was little scientific evidence to support either the effectiveness or safety of medical marijuana.

If Marijuana is Dangerous, Opioids are Nuclear

3 Ancillary Companies That Are Making Waves Across the Industry

Although many people associate the legal cannabis industry with the growing and selling of marijuana, the industry has evolved into much more than that.

Canada has proven itself to be a profitable new frontier for cannabis investors and this is just the first inning of a multi-decade growth cycle. While licensed producers have been at the forefront, new opportunities have emerged within the Canadian cannabis market and we want to highlight three undervalued opportunities.

5 Canadian Stocks Trending Up

The Canadian cannabis industry continues to offer investors great opportunity as the country plans to legalize recreational cannabis before July 1, 2018, and companies continue to execute ahead of this opportunity.

Although the industry has a major catalyst coming next year, Canadian cannabis stocks have been under significant pressure this year and the stocks have come well off its 2017 highs.

Corporate Update: Canabo Medical Continue to Execute Across the Board

Canabo Medical (CMM.V) (CAMDF: OTCQB) issued a corporate update this morning that highlighted some important company developments following the company’s listing on the TSX Venture Exchange. 

Executive Chairman Dr. Neil Smith outlined several key accomplishments that support its focus on being the dominant clinic network, research provider and data analytics source in the cannabis industry.

Operational Updates

Two Canadian Cannabis Industry Leaders Continue to Execute

Although the Canadian medical cannabis industry continues to see incremental growth, a number of issues will need to be resolved.   

The biggest challenge is the lack of education and assessment services on the patient and physician level. There are more than 130,000 registered patients and this number has continuesd to see double-digit percentage growth on a month-over-month basis.

Trump Tweets Triggering a Canadian Sell Off?

Despite the Dow rallying another 220 points and the Nasdaq ending the day above the 6,000, Canadian cannabis stocks were under pressure.

This pressure accelerated throughout the day and followed this tweet from President Trump, “Canada has made business for our dairy farmers in Wisconsin and other border states very difficult. We will not stand for this. Watch!”

Canadian Cannabis Companies Are Leveraging Big Data To Drive Big Returns For Investors

The Canadian cannabis industry continues to attract new investors ahead of its plan to legalize recreational cannabis before July 1, 2018.

Recent polls show that most people in the United States support legal cannabis. This is a significant but not surprising development because we have seen economies, both large and small benefit from cannabis legalization or deregulation.